You have 9 free searches left this month | for more free features.

Gamma-globulins

Showing 1 - 25 of 1,105

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Guillain-Barre Syndrome Trial in Wenzhou (Intravenous Immunoglobulins, Human, Methylprednisolone 500 MG Injection)

Recruiting
  • Guillain-Barre Syndrome
  • Intravenous Immunoglobulins, Human
  • Methylprednisolone 500 MG Injection
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Sep 11, 2023

Definition for Biliary Atresia Associated Cholangitis After

Recruiting
  • Biliary Atresia
  • Cholangitis
  • Intravenous Antibodies
  • Nanjing, Jiangsu, China
    NJMU
Jul 15, 2022

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)

Completed
  • Renal Transplant
  • Seoul, Korea, Republic of
  • +1 more
Oct 25, 2022

HFRS (Hemorrhagic Fever With Renal Syndrome) Trial in China (IVIG 20g/d, IVIG 10g/d)

Recruiting
  • HFRS (Hemorrhagic Fever With Renal Syndrome)
  • IVIG 20g/d
  • IVIG 10g/d
  • Guangshui, Hu Bei Province, China
  • +8 more
Aug 22, 2023

Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

Recruiting
  • Hypogammaglobulinemia
  • +2 more
  • Columbus, Ohio
  • +1 more
Jan 16, 2023

Obesity, Immune Deficiency Trial in Somerville (Institutional standard intravenous immune globulin treatment)

Recruiting
  • Obesity
  • Immune Deficiency
  • Institutional standard intravenous immune globulin treatment
  • Somerville, New Jersey
    Robert Wood Johnson University Hospital Somerset
Oct 10, 2022

Guillain-Barre Syndrome Trial (Efgartigimod Alfa-Fcab, Intravenous Immunoglobulin (IVIg))

Not yet recruiting
  • Guillain-Barre Syndrome
  • Efgartigimod Alfa-Fcab
  • Intravenous Immunoglobulin (IVIg)
  • (no location specified)
Jan 17, 2023

Severe Fever With Thrombocytopenia Syndrome Trial in China (Methylprednisolone, intravenous immunoglobulin, Tocilizumab)

Recruiting
  • Severe Fever With Thrombocytopenia Syndrome
  • Guangshui, Hubei, China
  • +9 more
Oct 31, 2022

Systemic Inflammation, Neuroinflammation, Microvascular Thrombosis Trial run by the National Institute of Neurological Disorders

Enrolling by invitation
  • Systemic Inflammation
  • +2 more
  • IV immunoglobulin
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

Recruiting
  • Lung Transplant
  • Hepatitis B
  • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
  • Philadelphia, Pennsylvania
    Hospital of University of Pennsylvania
Oct 1, 2022

Burn Shock Trial in Cairo (intravenous immunoglobulin)

Completed
  • Burn Shock
  • intravenous immunoglobulin
  • Cairo, Egypt
    Cairo University
Nov 13, 2022

Sickle Cell Disease, Pain Trial in Bronx (Immune Globulin Intravenous, Normal saline)

Recruiting
  • Sickle Cell Disease
  • Pain
  • Immune Globulin Intravenous
  • Normal saline
  • Bronx, New York
    Montefiore Medical Center
Jul 25, 2022

Dysmotility Syndrome, Autoimmunity Trial in Baltimore (Current Intravenous Immunoglobulin (IVIG) treatment, No Intravenous

Recruiting
  • Dysmotility Syndrome
  • Autoimmunity
  • Current Intravenous Immunoglobulin (IVIG) treatment
  • No Intravenous Immunoglobulin (IVIG) treatment
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Mar 8, 2022

Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin

Recruiting
  • Myasthenia Gravis
  • subcutaneous immunoglobulin (SCIG)
  • intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
  • Toronto, Ontario, Canada
    University Health Network
Nov 21, 2022

HIV Trial in Puerto Rico, United States (Globulin, Immune, Zidovudine)

Completed
  • HIV Infections
  • Downey, California
  • +50 more
Oct 27, 2021

PANS Pediatric Acute-Onset Neuropsychiatric Syndrome Trial in Gothenburg (Privigen Injectable Product (Intravenous

Recruiting
  • PANS Pediatric Acute-Onset Neuropsychiatric Syndrome
  • Privigen Injectable Product (Intravenous Immunoglobulin)
  • Gothenburg, Sweden
    Gillberg Neuropsychiatry Centre
Aug 13, 2022

Mucopolysaccharidosis (MPS), Hunter Syndrome Trial (ELAPRASE, Rituximab, Methotrexate)

Not yet recruiting
  • Mucopolysaccharidosis (MPS)
  • Hunter Syndrome
  • (no location specified)
Aug 8, 2022

Down Syndrome, Regression Trial (Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib)

Not yet recruiting
  • Down Syndrome
  • Regression
  • (no location specified)
Dec 14, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune

Recruiting
  • CIDP
  • +2 more
  • Intravenous immune globulin G
  • Subcutaneous immune globulin G
  • New Brunswick, New Jersey
    Rutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022

Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

Not yet recruiting
  • Immune Thrombocytopenia
  • Pregnancy Related
  • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
  • intravenous immunoglobulin
  • (no location specified)
Dec 1, 2022

Healthy, Communicable Diseases Trial (Vaccinia Immune Globulin (Human))

Withdrawn
  • Healthy
  • Communicable Diseases
  • Vaccinia Immune Globulin (Human)
  • (no location specified)
Oct 28, 2021

Guillain-Barré Syndrome Trial (Crovalimab, Placebo, Intravenous immunoglobulin therapy)

Not yet recruiting
  • Guillain-Barré Syndrome
  • (no location specified)
Aug 8, 2022

Primary Immunodeficiency Trial in United States (IGSC 20%)

Completed
  • Primary Immunodeficiency
  • IGSC 20%
  • Birmingham, Alabama
  • +11 more
Nov 2, 2022